Intervention Review

Inhaled bronchodilators for cystic fibrosis

  1. Clare Halfhide1,*,
  2. Hazel J Evans2,
  3. Jon Couriel1

Editorial Group: Cochrane Cystic Fibrosis and Genetic Disorders Group

Published Online: 20 JAN 2010

Assessed as up-to-date: 4 APR 2011

DOI: 10.1002/14651858.CD003428.pub2

Database Title

Additional Information

How to Cite

Halfhide C, Evans HJ, Couriel J. Inhaled bronchodilators for cystic fibrosis. Cochrane Database of Systematic Reviews 2005, Issue 4. Art. No.: CD003428. DOI: 10.1002/14651858.CD003428.pub2.

Author Information

  1. 1

    Alder Hey Children's NHS Foundation Trust, Respiratory Unit, Liverpool, Merseyside, UK

  2. 2

    Southampton University Hospitals Trust, Department of Respiratory Paediatrics, Southampton, UK

*Clare Halfhide, Respiratory Unit, Alder Hey Children's NHS Foundation Trust, Eaton Road, Liverpool, Merseyside, L12 2AP, UK. halfhide@liverpool.ac.uk. chalfhide@hotmail.com.

Publication History

  1. Publication Status: New search for studies and content updated (no change to conclusions)
  2. Published Online: 20 JAN 2010

SEARCH

ARTICLE TOOLS

View Full Article (HTML) Summary (58K)Standard (620K)Full (620K)

  1. Current Version

    Inhaled bronchodilators for cystic fibrosis

    Clare Halfhide, Hazel J Evans and Jon Couriel

    Article first published online: 20 JAN 2010 | DOI: 10.1002/14651858.CD003428.pub2

Previous versions of this article and their online publication dates

  1. Version 1

    Inhaled bronchodilators for cystic fibrosis

    J Couriel and H Bunn

    Article first published online: 20 JUL 2005 | DOI: 10.1002/14651858.CD003428

View Full Article (HTML) Summary (58K)Standard (620K)Full (620K)